Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
01.06.23 | IRLAB Therapeutics - On track for pirepemat in Phase IIb | 534 | Edison Investment Research | IRLAB has announced that it has activated all 38 sites in the ongoing Phase IIb pirepemat trial. This study is assessing pirepemat as a potential treatment to improve balance and reduce falls in patients... ► Artikel lesen | |
01.06.23 | Incannex Healthcare - Spotlight on Incannex's progress in psychedelics | 343 | Edison Investment Research | Incannex, an Australian-based biotech, has several active studies investigating cannabinoid combinations for a range of conditions, but is also focused on assessing psilocybin for the treatment of generalized... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 353 |
EVOTEC | 319 |
TUI | 232 |
NVIDIA | 194 |
DEUTSCHE BANK | 189 |
BAYER | 172 |
PLUG POWER | 156 |
RHEINMETALL | 147 |
NEL | 143 |
SIEMENS ENERGY | 129 |
COMMERZBANK | 115 |
BARRICK GOLD | 114 |
TESLA | 112 |
BASF | 110 |
VOLKSWAGEN | 105 |
RWE | 100 |
DEUTSCHE LUFTHANSA | 97 |
BYD | 95 |
ALLIANZ | 91 |
DEUTSCHE TELEKOM | 90 |
MERCEDES-BENZ | 89 |
RENK GROUP | 85 |
E.ON | 83 |
HEIDELBERGER DRUCK | 80 |
REDCARE PHARMACY | 78 |